NEXT Annual Report 2017

Download (PDF, 1.86MB)

The Value of Clinical Trials in Denmark

NEXT, The Danish Association of the Pharmaceutical Industry (Lif) and Invest in Denmark have published a report made by Copenhagen Economics which quantifies the value generated by clinical trials in Denmark.

The main conclusions of the report are: Clinical trials by pharmaceutical companies deliver value to the Danish society. On average, a clinical trial improves GDP by DKK 0.9m and the public budget by DKK 1.2m. The positive economic effects arise from trials conducted in Denmark through several drivers: More and better healthcare, highly productive jobs and new research in Life Sciences.

Executive summary here

Download (PDF, 452KB)

Full report is only available in danish

Download (PDF, 1.46MB)

Report from the Government

Unfortunately, the report is only available in Danish.

Download (PDF, 1.13MB)

Next annual report 2016

Read the report below

Download (PDF, 723KB)

Next annual report 2015

Read the report below

Download (PDF, 593KB)